![Xin Ni](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Xin Ni
Directeur Général chez Eddingpharm (Cayman), Inc.
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Xiao Ming Zou | M | 57 |
Eddingpharm (Cayman), Inc.
![]() Eddingpharm (Cayman), Inc. Pharmaceuticals: MajorHealth Technology Eddingpharm (Cayman) Inc. provides specialty pharmaceuticals marketing services. It focuses on medical nutrition and oncology therapeutic areas and creates a commercialization platform for pharmaceutical products. The company was founded by Xin Ni and Jiang Yao in 2001, and is headquartered in Hong Kong.
Taizhou EOC Pharma Co., Ltd.
![]() Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China.
EOC Pharma, Inc.
Edding Group Co., Ltd.
![]() Edding Group Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Edding Group Co., Ltd. is an investment holding company that engages in the manufacture, research and development, and sale of pharmaceutical products. Its business segment includes manufacturing and distribution of pharmaceutical products, and research and development of new drugs. The company was founded by Xin Ni in September 2001 and is headquartered in Shanghai, China.
Eddingpharm Investment Co. Ltd.
EOC Biologics (Hong Kong) Ltd.
EOC Pharma Ltd.
![]() EOC Pharma Ltd. Pharmaceuticals: MajorHealth Technology EOC Pharma Ltd. is a Chinese company that manufactures and commercializes products for breast cancer. The private company is based in Shanghai, China. | 14 ans |
Miao Jie Chen | F | 41 |
Edding Group Co., Ltd.
![]() Edding Group Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Edding Group Co., Ltd. is an investment holding company that engages in the manufacture, research and development, and sale of pharmaceutical products. Its business segment includes manufacturing and distribution of pharmaceutical products, and research and development of new drugs. The company was founded by Xin Ni in September 2001 and is headquartered in Shanghai, China.
Taizhou EOC Pharma Co., Ltd.
![]() Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China.
Eddingpharm Group (Cayman) Holdings Ltd.
EOC Pharma Ltd.
![]() EOC Pharma Ltd. Pharmaceuticals: MajorHealth Technology EOC Pharma Ltd. is a Chinese company that manufactures and commercializes products for breast cancer. The private company is based in Shanghai, China.
Eddingpharm International Holdings Ltd.
![]() Eddingpharm International Holdings Ltd. Medical/Nursing ServicesHealth Services Part of Eddingpharm (Cayman), Inc., Eddingpharm International Holdings Ltd. engages in cancer, infectious, and respiratory therapies. The company is based in Hong Kong, Hong Kong. | 8 ans |
Qing Xu | M | 53 |
Taizhou EOC Pharma Co., Ltd.
![]() Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China.
Edding Group Co., Ltd.
![]() Edding Group Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Edding Group Co., Ltd. is an investment holding company that engages in the manufacture, research and development, and sale of pharmaceutical products. Its business segment includes manufacturing and distribution of pharmaceutical products, and research and development of new drugs. The company was founded by Xin Ni in September 2001 and is headquartered in Shanghai, China.
Jiangsu University
| 9 ans |
Xu Jing Su | M | 41 |
Taizhou EOC Pharma Co., Ltd.
![]() Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 5 ans |
Jun Jun Wang | M | 40 |
Edding Group Co., Ltd.
![]() Edding Group Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Edding Group Co., Ltd. is an investment holding company that engages in the manufacture, research and development, and sale of pharmaceutical products. Its business segment includes manufacturing and distribution of pharmaceutical products, and research and development of new drugs. The company was founded by Xin Ni in September 2001 and is headquartered in Shanghai, China. | 8 ans |
Xiao Ting Sun | F | 42 |
Edding Group Co., Ltd.
![]() Edding Group Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Edding Group Co., Ltd. is an investment holding company that engages in the manufacture, research and development, and sale of pharmaceutical products. Its business segment includes manufacturing and distribution of pharmaceutical products, and research and development of new drugs. The company was founded by Xin Ni in September 2001 and is headquartered in Shanghai, China. | 6 ans |
Guang Peng Liang | M | 48 |
Taizhou EOC Pharma Co., Ltd.
![]() Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China.
Edding Group Co., Ltd.
![]() Edding Group Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Edding Group Co., Ltd. is an investment holding company that engages in the manufacture, research and development, and sale of pharmaceutical products. Its business segment includes manufacturing and distribution of pharmaceutical products, and research and development of new drugs. The company was founded by Xin Ni in September 2001 and is headquartered in Shanghai, China. | 8 ans |
Xiao Tong Li | F | 55 |
Edding Group Co., Ltd.
![]() Edding Group Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Edding Group Co., Ltd. is an investment holding company that engages in the manufacture, research and development, and sale of pharmaceutical products. Its business segment includes manufacturing and distribution of pharmaceutical products, and research and development of new drugs. The company was founded by Xin Ni in September 2001 and is headquartered in Shanghai, China.
China Europe International Business School
| 8 ans |
Hong Yu Duan | F | 55 |
Edding Group Co., Ltd.
![]() Edding Group Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Edding Group Co., Ltd. is an investment holding company that engages in the manufacture, research and development, and sale of pharmaceutical products. Its business segment includes manufacturing and distribution of pharmaceutical products, and research and development of new drugs. The company was founded by Xin Ni in September 2001 and is headquartered in Shanghai, China. | - |
Yong Hong Yue | M | 50 |
Edding Group Co., Ltd.
![]() Edding Group Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Edding Group Co., Ltd. is an investment holding company that engages in the manufacture, research and development, and sale of pharmaceutical products. Its business segment includes manufacturing and distribution of pharmaceutical products, and research and development of new drugs. The company was founded by Xin Ni in September 2001 and is headquartered in Shanghai, China. | - |
Huan Yang | M | 41 |
Taizhou EOC Pharma Co., Ltd.
![]() Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 5 ans |
He Ting Li | M | 49 |
Taizhou EOC Pharma Co., Ltd.
![]() Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 12 ans |
Qiang Zhou | M | 58 |
Taizhou EOC Pharma Co., Ltd.
![]() Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 4 ans |
Hong Yan Wang | F | 57 |
Taizhou EOC Pharma Co., Ltd.
![]() Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 4 ans |
Wen Kong | M | 57 |
Taizhou EOC Pharma Co., Ltd.
![]() Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 6 ans |
Po Man Mak | F | 40 |
Edding Group Co., Ltd.
![]() Edding Group Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Edding Group Co., Ltd. is an investment holding company that engages in the manufacture, research and development, and sale of pharmaceutical products. Its business segment includes manufacturing and distribution of pharmaceutical products, and research and development of new drugs. The company was founded by Xin Ni in September 2001 and is headquartered in Shanghai, China. | 4 ans |
Song Zhou | M | 43 |
Taizhou EOC Pharma Co., Ltd.
![]() Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 5 ans |
Ting Fu | F | 32 |
Taizhou EOC Pharma Co., Ltd.
![]() Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 5 ans |
Zheng Yao | F | 40 |
Taizhou EOC Pharma Co., Ltd.
![]() Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 5 ans |
Cui Ping Gu | M | 44 |
Taizhou EOC Pharma Co., Ltd.
![]() Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 7 ans |
Wei Dong Huang | M | 54 |
Edding Group Co., Ltd.
![]() Edding Group Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Edding Group Co., Ltd. is an investment holding company that engages in the manufacture, research and development, and sale of pharmaceutical products. Its business segment includes manufacturing and distribution of pharmaceutical products, and research and development of new drugs. The company was founded by Xin Ni in September 2001 and is headquartered in Shanghai, China. | 4 ans |
Hao Zheng | M | 40 |
Edding Group Co., Ltd.
![]() Edding Group Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Edding Group Co., Ltd. is an investment holding company that engages in the manufacture, research and development, and sale of pharmaceutical products. Its business segment includes manufacturing and distribution of pharmaceutical products, and research and development of new drugs. The company was founded by Xin Ni in September 2001 and is headquartered in Shanghai, China. | 5 ans |
Yi Min Zhang | M | 70 |
China Europe International Business School
| 20 ans |
Ding Bo Xu | M | 62 |
China Europe International Business School
| 20 ans |
Hua Zhang | F | 45 |
Edding Group Co., Ltd.
![]() Edding Group Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Edding Group Co., Ltd. is an investment holding company that engages in the manufacture, research and development, and sale of pharmaceutical products. Its business segment includes manufacturing and distribution of pharmaceutical products, and research and development of new drugs. The company was founded by Xin Ni in September 2001 and is headquartered in Shanghai, China. | 19 ans |
Jing Zhai | F | 41 |
Edding Group Co., Ltd.
![]() Edding Group Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Edding Group Co., Ltd. is an investment holding company that engages in the manufacture, research and development, and sale of pharmaceutical products. Its business segment includes manufacturing and distribution of pharmaceutical products, and research and development of new drugs. The company was founded by Xin Ni in September 2001 and is headquartered in Shanghai, China. | 9 ans |
Julia Miao | F | - |
Eddingpharm (Cayman), Inc.
![]() Eddingpharm (Cayman), Inc. Pharmaceuticals: MajorHealth Technology Eddingpharm (Cayman) Inc. provides specialty pharmaceuticals marketing services. It focuses on medical nutrition and oncology therapeutic areas and creates a commercialization platform for pharmaceutical products. The company was founded by Xin Ni and Jiang Yao in 2001, and is headquartered in Hong Kong. | 20 ans |
Guo Wei Wang | M | 63 |
Edding Group Co., Ltd.
![]() Edding Group Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Edding Group Co., Ltd. is an investment holding company that engages in the manufacture, research and development, and sale of pharmaceutical products. Its business segment includes manufacturing and distribution of pharmaceutical products, and research and development of new drugs. The company was founded by Xin Ni in September 2001 and is headquartered in Shanghai, China. | 12 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Hong Wei Ren | M | - |
Jiangsu University
| 14 ans |
Hai Long Zhu | M | 56 |
China Europe International Business School
| - |
Hong Zhao | F | 54 |
China Europe International Business School
| 2 ans |
Xing Fang | M | 52 |
China Europe International Business School
| 4 ans |
Mei Zhong | F | 53 |
China Europe International Business School
| 2 ans |
Yong Liu | M | 57 |
China Europe International Business School
| 2 ans |
Da Lun Dong | M | 60 |
China Europe International Business School
| 2 ans |
Mei Pan | F | 54 |
China Europe International Business School
| 2 ans |
Hai Yan Tang | F | 53 |
China Europe International Business School
| 2 ans |
Feng Wen | M | 55 |
China Europe International Business School
| 2 ans |
Di Wu | M | 51 |
China Europe International Business School
| 2 ans |
Xin Zhou | M | 53 |
China Europe International Business School
| 2 ans |
Xiong Hu | M | 52 |
China Europe International Business School
| 2 ans |
Xiao Yan Hu | F | 52 |
China Europe International Business School
| 2 ans |
Feng Qi | M | 54 |
China Europe International Business School
| 2 ans |
Shu Guang Liu | M | 55 |
China Europe International Business School
| 2 ans |
Guo Jian Yue | M | 59 |
China Europe International Business School
| 2 ans |
Hao Wang | M | 56 |
China Europe International Business School
| 2 ans |
Shao-Tong Bai | M | 60 |
China Europe International Business School
| 2 ans |
Warren Wang | M | - |
China Europe International Business School
| 2 ans |
Mian Huan Li | M | 54 |
China Europe International Business School
| 2 ans |
Min Ma | M | 57 |
China Europe International Business School
| 2 ans |
Jun Lu | M | 50 |
China Europe International Business School
| 2 ans |
Ran Ting Qian | F | 49 |
China Europe International Business School
| 2 ans |
Mei Lu | F | 62 |
China Europe International Business School
| 2 ans |
Qiang Li | M | 56 |
China Europe International Business School
| 2 ans |
Lin Long Yao | M | 60 |
China Europe International Business School
| 2 ans |
Jia He | M | 70 |
China Europe International Business School
| 3 ans |
Shun Qiang Zhao | M | 56 |
China Europe International Business School
| 2 ans |
Jin Wei Zhu | M | 55 |
China Europe International Business School
| 2 ans |
Quan Hong Yuan | M | 50 |
China Europe International Business School
| 2 ans |
Arthur Yu Chen | M | 48 |
China Europe International Business School
| 2 ans |
Chen Guang Xie | M | 61 |
China Europe International Business School
| 2 ans |
Jun Yong Wei | M | 55 |
China Europe International Business School
| 2 ans |
Zhi Ping Gao | M | 61 |
China Europe International Business School
| 2 ans |
Wei Li | M | 58 |
China Europe International Business School
| 2 ans |
Jun Long Huang | M | 59 |
China Europe International Business School
| 2 ans |
Ming Gui Zou | M | 60 |
China Europe International Business School
| 2 ans |
Jun Sheng Zhu | M | 64 |
China Europe International Business School
| 2 ans |
Hong Ning Sun | M | 63 |
China Europe International Business School
| 2 ans |
Li Cheng Jiang | M | 66 |
China Europe International Business School
| 2 ans |
Fang Zhu | F | 54 |
China Europe International Business School
| 2 ans |
Yabo Zhang | M | 50 |
China Europe International Business School
| 2 ans |
Zong Min Wu | M | 58 |
China Europe International Business School
| 2 ans |
Yu Feng Chi | M | 53 |
China Europe International Business School
| 2 ans |
Hong Yan | M | 57 |
China Europe International Business School
| 2 ans |
Lu Yun Zhang | F | 63 |
China Europe International Business School
| 2 ans |
Ding Wu | M | 59 |
China Europe International Business School
| 2 ans |
Lai Suo Li | M | 63 |
China Europe International Business School
| 2 ans |
Jian Zhu | M | 49 |
China Europe International Business School
| 2 ans |
Jing Lou | M | 61 |
China Europe International Business School
| 2 ans |
Li Qing Zeng | M | 54 |
China Europe International Business School
| 2 ans |
Weimin Yin | M | 52 |
China Europe International Business School
| 2 ans |
Wei Dong Shi | M | 57 |
China Europe International Business School
| 2 ans |
Wei Yao Wang | M | 61 |
China Europe International Business School
| 2 ans |
Bing Wang | M | 52 |
China Europe International Business School
| 2 ans |
Xiang Rong Li | F | 51 |
China Europe International Business School
| 2 ans |
Rui Lin Song | M | 61 |
China Europe International Business School
| 1 ans |
Yong Jun Wu | M | 54 |
Jiangsu University
| 1 ans |
Xiao Ou Zhang | M | 51 |
China Europe International Business School
| 2 ans |
Bin Zhou | M | 56 |
China Europe International Business School
| 2 ans |
Xiao Yan Sun | F | 52 |
China Europe International Business School
| 2 ans |
Po Yi Chang | M | - |
China Europe International Business School
| 2 ans |
Jinghong Yang | M | 60 |
China Europe International Business School
| 4 ans |
Xin Li | M | 54 |
China Europe International Business School
| 2 ans |
Zeng Gen Zhang | M | 59 |
China Europe International Business School
| 2 ans |
Yu Shang | M | 45 |
China Europe International Business School
| 2 ans |
Ping Chen | M | 59 |
China Europe International Business School
| 2 ans |
Jun Mo | M | 57 |
China Europe International Business School
| 2 ans |
Cao He | M | 69 |
China Europe International Business School
| 2 ans |
Shi Hongchao | M | 54 |
China Europe International Business School
| 2 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Chine | 88 | 88,89% |
Îles Cayman | 15 | 15,15% |
Hong Kong | 3 | 3,03% |
Etats-Unis | 1 | 1,01% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations